These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 4325031)

  • 21. Kinetics of the plasma and lung angiotensin I converting enzymes.
    Huggins CG; Corcoran RJ; Gordon JS; Henry HW; John JP
    Circ Res; 1970 Jul; 27(1 Suppl 1):93-108. PubMed ID: 4317861
    [No Abstract]   [Full Text] [Related]  

  • 22. Substrate requirements for angiotensin I conversion in vivo and in vitro.
    Oparil S; Koerner T; Tregear GW; Barnes BA; Haber E
    Circ Res; 1973 Apr; 32(4):415-23. PubMed ID: 4349742
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of neutral endopeptidase inhibition and combined angiotensin converting enzyme and neutral endopeptidase inhibition on angiotensin and bradykinin peptides in rats.
    Campbell DJ; Anastasopoulos F; Duncan AM; James GM; Kladis A; Briscoe TA
    J Pharmacol Exp Ther; 1998 Nov; 287(2):567-77. PubMed ID: 9808682
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanism of inactivation of oxytocin by rat kidney enzymes.
    Koida M; Glass JD; Schwartz IL; Walter R
    Endocrinology; 1971 Mar; 88(3):633-43. PubMed ID: 4322383
    [No Abstract]   [Full Text] [Related]  

  • 25. On the specificity and pH dependence of ficin-catalyzed hydrolyses. Some comparisons with bromelain specificity.
    Kortt AA; Hinds JA; Zerner B
    Biochemistry; 1974 May; 13(10):2029-37. PubMed ID: 4363754
    [No Abstract]   [Full Text] [Related]  

  • 26. A dipeptidyl carboxypeptidase that converts angiotensin I and inactivates bradykinin.
    Yang HY; Erdös EG; Levin Y
    Biochim Biophys Acta; 1970 Aug; 214(2):374-6. PubMed ID: 4322742
    [No Abstract]   [Full Text] [Related]  

  • 27. ACE mediates ventilator-induced lung injury in rats via angiotensin II but not bradykinin.
    Wösten-van Asperen RM; Lutter R; Haitsma JJ; Merkus MP; van Woensel JB; van der Loos CM; Florquin S; Lachmann B; Bos AP
    Eur Respir J; 2008 Feb; 31(2):363-71. PubMed ID: 17959639
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kininase and anti-inflammatory activities of acid carboxypeptidase from Penicillium janthinellum.
    Yokoyama S; Oobayashi A; Tanabe O; Ohata K; Shibata Y
    Experientia; 1975 Oct; 31(10):1122-4. PubMed ID: 1204716
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation of pulmonary structure with pharmacokinetic function.
    Ryan JW; Ryan US
    Agents Actions; 1976 Jul; 6(4):510-5. PubMed ID: 183486
    [No Abstract]   [Full Text] [Related]  

  • 30. Hydrolysis of bradykinin and its higher homologues by angiotensin-converting enzyme.
    Dorer F; Ryan JW; Stewart JM
    Biochem J; 1974 Sep; 141(3):915-7. PubMed ID: 4377109
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Vasoactive substance and the lung].
    Kitamura S
    Kokyu To Junkan; 1973 Aug; 21(8):688-700. PubMed ID: 4354545
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacokinetic function of the pulmonary circulation.
    Bakhle YS; Vane JR
    Physiol Rev; 1974 Oct; 54(4):1007-45. PubMed ID: 4371230
    [No Abstract]   [Full Text] [Related]  

  • 33. The effects of pathophysiologic state on the metabolism of vasoactive peptides by mammalian lung.
    Stalcup SA; Leuenberger P; Greenbaum LM; Mellins RB; Turino GM
    Bull Eur Physiopathol Respir; 1979; 15(5):1031-44. PubMed ID: 228783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolism of vasoactive peptides by human endothelial cells in culture. Angiotensin I converting enzyme (kininase II) and angiotensinase.
    Johnson AR; Erdös EG
    J Clin Invest; 1977 Apr; 59(4):684-95. PubMed ID: 191471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction between neutral endopeptidase and angiotensin converting enzyme inhibition in rats with myocardial infarction: effects on cardiac hypertrophy and angiotensin and bradykinin peptide levels.
    Duncan AM; James GM; Anastasopoulos F; Kladis A; Briscoe TA; Campbell DJ
    J Pharmacol Exp Ther; 1999 Apr; 289(1):295-303. PubMed ID: 10087017
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Peptides--inhibitors of carboxycathepsin (peptidyl-dipeptidase A) and their role in clinical medicine].
    Orekhovich VN; Eliseeva IuE; Pavlikhina LV; Krit NA; Filatova MP
    Vopr Med Khim; 1984; 30(3):51-6. PubMed ID: 6206649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inactivation of bradykinin the plumonary circulation.
    Stewart JM
    Agents Actions; 1976 Jul; 6(4):494-7. PubMed ID: 961547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The lung as a chemical filter.
    Junod AF
    Ergeb Inn Med Kinderheilkd; 1974; 36():1-18. PubMed ID: 4375560
    [No Abstract]   [Full Text] [Related]  

  • 39. Angiotensin II generated by a human renal carboxypeptidase.
    Changaris DG; Miller JJ; Levy RS
    Biochem Biophys Res Commun; 1986 Jul; 138(2):573-9. PubMed ID: 3741422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Several aspects of the barrier function of the lungs with regard to a series of vasoactive substances].
    Urazaeva ZV; Dubileĭ PV
    Usp Sovrem Biol; 1977; 83(1):139-53. PubMed ID: 331723
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.